Search results for: 'termination code ott of contract'

This edition of IT, Computing and Communications (ITCC) Technology Opportunity Engine (TOE) explores significant advancements in IT and computing, focusing on enterprise solutions driving digital transformation across industries. It highlights a various type of AI-enabled solutions with real-time monitoring and automation, conversational platforms,...

21 Mar 2025  |  Global  |  Market Research

Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030

The CRO Industry is Witnessing Transformational Growth Due to Industry Convergence and an Increasing Reliance on the Functional Service Provider (FSP) Model

Infographics

×

As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining their processes to ensure better clinical trial tu...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

For airport organizations, traffic growth poses both an opportunity and a challenge: it will feed more passengers and drive revenue, but it may also create overcapacity involving longer waiting time and queuing at each checkpoint, thus increasing passenger dissatisfaction and decreasing their willingness to consume during dwell time. In response, i...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...

The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 4...

Modern application environments are built on cloud-native architectures, IaC, and microservices deployed through Kubernetes and containers. While these technologies deliver agility and scalability, they also significantly expand the attack surface, making vulnerabilities more difficult to track and remediate across the software development life cyc...

This document provides a comprehensive study of chemical anchors, including detailed estimates for the years 2024 and 2031. For 2024, the analysis presents revenue and volume projections segmented by key regions—Americas, Europe, APAC, and MEASA—as well as by application segments comprising infrastructure, industrial, commercial, and residential ma...